CN Patent

CN102086172A — 沙格列汀的药用盐及其制备方法

Assigned to Individual · Expires 2011-06-08 · 15y expired

What this patent protects

本发明提供了沙格列汀新的药用盐，尤其是甲磺酸盐、马来酸盐、苹果酸盐、丁二酸盐和枸橼酸盐及其制备方法，具有稳定性好，不易降解的优点，可与药学上可接受的载体通过常规的制剂技术生产出各种具有质量可控、成本低廉和适合工艺化生产的制剂，用于治疗和/或预防糖尿病。

USPTO Abstract

本发明提供了沙格列汀新的药用盐，尤其是甲磺酸盐、马来酸盐、苹果酸盐、丁二酸盐和枸橼酸盐及其制备方法，具有稳定性好，不易降解的优点，可与药学上可接受的载体通过常规的制剂技术生产出各种具有质量可控、成本低廉和适合工艺化生产的制剂，用于治疗和/或预防糖尿病。

Drugs covered by this patent

saxagliptin-hydrochloride (SAXAGLIPTIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN102086172A
Jurisdiction: CN
Classification: —
Expires: 2011-06-08
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.